clonazepam has been researched along with zolpidem in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 6 (17.65) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 12 (35.29) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Besnard, F; Costa, B; Greco, G; Lavecchia, A; Marini, AM; Martini, C; Novellino, E; Primofiore, G; Settimo, FD; Taliani, S; Trincavelli, L | 1 |
| Besnard, F; Cosimelli, B; Costa, B; Da Settimo, F; Greco, G; Martini, C; Montali, M; Novellino, E; Primofiore, G; Salerno, S; Taliani, S | 1 |
| Besnard, F; Calderone, V; Cosimelli, B; Da Settimo, F; Greco, G; La Motta, C; Marini, AM; Martini, C; Montali, M; Novellino, E; Patrizi, MP; Primofiore, G; Sergianni, V; Simorini, F; Taliani, S | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antonacci, MD; Costa, E; Giusti, P; Guidotti, A; Massotti, M; Memo, M; Schlichting, JL | 1 |
| De Luca, C; De Medici, D; Massotti, M | 1 |
| Cooper, SJ; Yerbury, RE | 1 |
| Ator, NA; Sannerud, CA | 1 |
| Auta, J; Costa, E; Guidotti, A; Kozikowski, A; Ma, D; Romeo, E | 1 |
| Coulter, DA; Gibbs, JW; Shumate, MD | 1 |
| Leeuwin, RS; van Wilgenburg, H; Zeegers, A | 1 |
| Copolov, D; Dean, B; McLeod, M; Pralong, D | 1 |
| Dean, B; McLeod, M; Scarr, E | 1 |
| Lopes, DV; Mendonça-Silva, DL; Noël, F; Thibaut, JP | 1 |
| Burin, E; Dally, S; Djezzar, S; Questel, F | 1 |
| Carney, PR; Davis, L; Dillard, SC; Geyer, JD; Ward, LC | 1 |
| Chen, CY; Huang, CC; Kuo, SC; Lee, WK; Shiah, IS; Wang, TY | 1 |
| Ji, KH; Yun, CH | 1 |
| Chèze, M; Deveaux, M; Hoizey, G; Muckensturm, A; Pépin, G | 1 |
| Ahmadi, F; Alimadadi, A; Chamani, N; Dalili, S; Dashti-Khavidaki, S; Ghaeli, P; Hajhossein Talasaz, A; Khalili, H; Lessan-Pezeshki, M | 1 |
| Aursnes, I; Bjørner, T; Skomedal, T; Tvete, IF | 1 |
| Chen, CK; Chen, YC; Chou, MC; Chou, WJ; Wang, LJ | 1 |
| Ebert, B; Jensen, HS; Lee, D; Nichol, K | 1 |
| Chen, H; He, J; Liu, Y; Luan, X; Qiu, H; Shen, H; Tu, X; Zhao, K; Zhu, Z | 1 |
| Bianco, G; Castelnovo, A; Chiaro, G; Maffei, P; Manconi, M | 1 |
| Bajaj, A; Bajaj, V; Kalra, I; Kumar, R; Sharma, D | 1 |
| Concheiro, M; Cruz, A; de-Castro-Ríos, A; Lendoiro, E; López-Rabuñal, A; López-Rivadulla, M | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Adhikari, S; Barron, LP; Bhatnagar, A; Bowes, DA; Coronado-Apodaca, KG; Driver, EM; Halden, RU; Kumar, R; Martínez-Ruiz, M; McCall, KL; Melchor-Martínez, EM; Ng, KT; Oyervides-Muñoz, MA; Parra-Saldivar, R; Piper, BJ; Smith, T; Sosa-Hernandez, JE | 1 |
1 review(s) available for clonazepam and zolpidem
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for clonazepam and zolpidem
| Article | Year |
|---|---|
Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis.
Topics: Adult; Aged; Clonazepam; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; GABA Modulators; Humans; Hypnotics and Sedatives; Kidney Failure, Chronic; Male; Middle Aged; Polysomnography; Pyridines; Quality of Life; Renal Dialysis; Sleep; Sleep Wake Disorders; Treatment Outcome; Zolpidem | 2011 |
32 other study(ies) available for clonazepam and zolpidem
| Article | Year |
|---|---|
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
Topics: Amides; Animals; Brain; Cattle; Glyoxylates; In Vitro Techniques; Indoles; Ligands; Models, Molecular; Radioligand Assay; Receptors, GABA-A; Structure-Activity Relationship | 2001 |
High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives.
Topics: Animals; Binding, Competitive; Brain; Cattle; Cell Line; Chlorides; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; In Vitro Techniques; Models, Molecular; Protein Isoforms; Radioligand Assay; Rats; Recombinant Proteins; Structure-Activity Relationship; Triazines; Triazoles | 2005 |
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Topics: Amides; Animals; Cattle; Cell Line; Cerebral Cortex; GABA-A Receptor Agonists; Glyoxylates; Hypnotics and Sedatives; In Vitro Techniques; Indoles; Ligands; Male; Mice; Mice, Inbred BALB C; Molecular Conformation; Motor Activity; Radioligand Assay; Rats; Structure-Activity Relationship | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
Topics: Animals; Benzodiazepines; Central Nervous System; Clonazepam; Hypnotics and Sedatives; Ligands; Male; Motor Activity; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Zolpidem | 1991 |
Relative efficacies of benzodiazepine receptor agonists in affecting red nucleus electrical activity in rabbits.
Topics: Animals; Bicuculline; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Flunitrazepam; Imidazoles; Isoquinolines; Male; Pentylenetetrazole; Pyridazines; Pyridines; Rabbits; Receptors, GABA-A; Red Nucleus; Zolpidem | 1990 |
Clonazepam selectively increases saccharin ingestion in a two-choice test.
Topics: Administration, Oral; Animals; Clonazepam; Drinking Behavior; Male; Pyridines; Rats; Receptors, GABA-A; Saccharin; Taste; Zolpidem | 1988 |
Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Clonazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; GABA Modulators; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Midazolam; Pyridines; Rats; Rats, Sprague-Dawley; Zolpidem | 1995 |
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
Topics: Aggression; Allosteric Regulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Clonazepam; Desoxycorticosterone; Flumazenil; Imidazoles; Indoleacetic Acids; Isoniazid; Isoquinolines; Mitochondria; Phobic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, GABA-A; Seizures; Zolpidem | 1993 |
Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons.
Topics: Animals; Clonazepam; Epilepsy, Temporal Lobe; Evoked Potentials; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Logistic Models; Patch-Clamp Techniques; Pilocarpine; Pyridines; Rats; Receptors, GABA-A; Zinc; Zolpidem | 1997 |
Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: a comparative study.
Topics: Animals; Benzodiazepines; Cardiac Output; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Heart; In Vitro Techniques; Isoquinolines; Myocardial Contraction; Perfusion; Pyridines; Rats; Receptors, GABA-A; Zolpidem | 1998 |
The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.
Topics: Cerebellum; Clonazepam; Flumazenil; Frontal Lobe; GABA Agents; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Humans; Male; Middle Aged; Neurons; Protein Binding; Pyridines; Radioligand Assay; Receptors, GABA-A; Synaptic Transmission; Tritium; Zolpidem | 2002 |
Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
Topics: Adult; Aged; Binding, Competitive; Bipolar Disorder; Brain Chemistry; Clonazepam; Female; Flumazenil; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Humans; Male; Middle Aged; Muscimol; Protein Subunits; Pyridines; Radioligand Assay; Receptors, GABA-A; Schizophrenia; Zolpidem | 2005 |
Characterization of two classes of benzodiazepine binding sites in Schistosoma mansoni.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Clonazepam; Diazepam; Flunitrazepam; GABA Agonists; GABA Modulators; Inhibitory Concentration 50; Isoquinolines; Ligands; Male; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Schistosoma mansoni; Synaptosomes; Temperature; Time Factors; Tritium; Zolpidem | 2007 |
Chemical submission: results of 4-year French inquiry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzodiazepines; Bromazepam; Child; Child Abuse; Child, Preschool; Clonazepam; Crime; Data Collection; Female; Flunitrazepam; Homicide; Humans; Male; Middle Aged; Psychotropic Drugs; Pyridines; Rape; Sodium Oxybate; Theft; Young Adult; Zolpidem | 2009 |
Antidepressant medications, neuroleptics, and prominent eye movements during NREM sleep.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Eye Movement Measurements; Eye Movements; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Pyridines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Young Adult; Zolpidem | 2009 |
Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression.
Topics: Antipsychotic Agents; Bipolar Disorder; Clonazepam; Dibenzothiazepines; Female; Humans; Hypnotics and Sedatives; Middle Aged; Pyridines; Quetiapine Fumarate; Self Medication; Substance-Related Disorders; Zolpidem | 2009 |
Zolpidem-induced sleep-related eating disorder.
Topics: Benzothiazoles; Clonazepam; Dopamine Agonists; Feeding and Eating Disorders; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pramipexole; Pyridines; Restless Legs Syndrome; Sleep Wake Disorders; Zolpidem | 2010 |
A tendency for re-offending in drug-facilitated crime.
Topics: Adult; Anti-Anxiety Agents; Chromatography, Liquid; Clonazepam; Crime Victims; Doxylamine; Drug Combinations; Female; Flunitrazepam; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Limit of Detection; Lorazepam; Male; Mass Spectrometry; Middle Aged; Phenothiazines; Pyridines; Rape; Recurrence; Zolpidem | 2010 |
[Dispensing of benzodiazepines and Z drugs by Norwegian pharmacies 2004-2011].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Drug Prescriptions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Norway; Pharmaceutical Services; Piperazines; Practice Guidelines as Topic; Pyridines; Registries; Sex Factors; Zolpidem | 2013 |
Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chlordiazepoxide; Clonazepam; Estazolam; GABA Modulators; Humans; Hypnotics and Sedatives; National Health Programs; Polypharmacy; Prescription Drugs; Pyridines; Registries; Taiwan; Time Factors; Zolpidem | 2014 |
Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for α₂- versus α₁-GABA(A)-receptor complexes.
Topics: Allosteric Site; Animals; Anticonvulsants; Benzodiazepines; Binding Sites; Brain; Clobazam; Clonazepam; HEK293 Cells; Humans; Kinetics; Male; Mice; Mutation; Protein Binding; Pyridines; Rats; Receptors, GABA-A; Seizures; Zolpidem | 2014 |
Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months.
Topics: Adult; Antidepressive Agents; Azabicyclo Compounds; Biomarkers; Case-Control Studies; Chronic Disease; Clonazepam; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Odds Ratio; Piperazines; Prognosis; Pyridines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Zolpidem | 2017 |
Severe Chronic Abuse of Zolpidem in Refractory Insomnia.
Topics: Aged; Anticonvulsants; Chronic Disease; Clonazepam; Female; Hospitalization; Humans; Levetiracetam; Pregabalin; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Zolpidem | 2018 |
A case of zolpidem dependence with extremely high daily doses.
Topics: Clonazepam; GABA Modulators; Humans; Hypnotics and Sedatives; Irritable Mood; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2019 |
LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium.
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Chromatography, Liquid; Clonazepam; Forensic Toxicology; Humans; Limit of Detection; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Zolpidem | 2020 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; Nordazepam; Pandemics; Tandem Mass Spectrometry; Temazepam; United States; Wastewater; Zolpidem | 2023 |